Get 40% Off
🤯 Perficient is up a mind-blowing 53%. Our ProPicks AI saw the buying opportunity in March.Read full update

Ventas' (VTR) Q1 FFO Beats Estimates, Revenues Rise

Published 04/29/2016, 01:36 AM
Updated 07/09/2023, 06:31 AM

Ventas, Inc.’s (NYSE:VTR) first-quarter 2016, normalized funds from operations (“FFO”) of $1.04 per share surpassed the Zacks Consensus Estimate of $1.02. On a comparable basis, adjusting the effect of spin-offs, normalized FFO for the quarter grew 7% year over year.

The company posted revenues of $852.3 million in the first quarter, which beat the Zacks Consensus Estimate of $814 million. Further, it compared favorably with the year-ago tally of $805.6 million.

Behind the Headlines

For first-quarter 2016, same-store cash NOI growth for total portfolio (1,069) assets was 2.9%, excluding certain items and 1.7% on a reported basis. Notably, triple net same-store cash NOI declined 0.3%; the seniors housing operating portfolio (“SHOP”) same-store NOI grew 2.9% and the medical office building (“MOB”) portfolio rose 4.2%.

Notable Portfolio Activity

During first-quarter 2016, the company made $154 investments. This included secured debt investment of $140 million in class-A life science properties situated in Cambridge, MA, San Francisco, CA and San Diego, CA. Also, during the quarter, the company financed $37 million from its pipeline of $500 million for top-quality development and redevelopment projects.

Liquidity

Presently, the company has around $1.8 billion available under its revolving credit facility and $53 million of cash or cash equivalent in hand.

2016 Outlook

Ventas reaffirms its 2016 normalized FFO per share outlook in the range of $4.07–$4.15, denoting expected growth of 3–5% from 2015 on a comparable basis. The company anticipates same-store cash net operating income growth of 1.5–3% in 2016. Further, for 2016 Ventas estimates dispositions of $500 million and intends to use the net proceeds for reinvestment into acquisitions and debt repayment.

Our Take

Ventas’ better-than-expected performance is encouraging. Going forward, we believe the company’s adequate size and scale would help it capitalize on opportunities such as increasing healthcare spending, aging population and a rise in insured individuals. Yet, stiff competition and a projected rise in interest rates keep us concerned.

Ventas currently has a Zacks Rank #4 (Sell).

We now look forward to other REITs that are scheduled to release first-quarter 2016 results next week. These include General Growth Properties, Inc (NYSE:GGP) , Taubman Centers, Inc. (NYSE:TCO) and Vornado Realty Trust (NYSE:VNO) .

Note: FFO, a widely used metric to gauge the performance of REITs, is obtained after adding depreciation and amortization and other non-cash expenses to net income.


TAUBMAN CENTERS (TCO): Free Stock Analysis Report

GENL GRWTH PPTY (GGP): Free Stock Analysis Report

VENTAS INC (VTR): Free Stock Analysis Report

VORNADO RLTY TR (VNO): Free Stock Analysis Report

To read this article on Zacks.com click here.

Zacks Investment Research

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.